Epidemiological studies of<unk>  are difficult as many physicians are unaware of the diagnosis or they may miss the syndrome due to its variable manifestations. In 1998 a survey conducted in England found that 85% of the general practitioners that had prescribed the antidepressant nefazodone were unaware of<unk> . The incidence may be increasing as a larger number of pro-serotonergic drugs (drugs which increase<unk>  levels) are now being used in clinical practice. One postmarketing surveillance study identified an incidence of 0.4 cases per 1000 patient-months for patients who were taking nefazodone. Additionally, around 14 to 16 percent of persons who overdose on<unk> RIs are thought to develop<unk> .
Serotonin syndrome
Malignant hyperthermia
Cannabinoid hyperemesis syndrome
Neuroleptic malignant syndrome
Post-acute-withdrawal syndrome
Methanol toxicity
Glycine encephalopathy
Anticonvulsant hypersensitivity syndrome